A kinetic scheme postulating the rapid formation of a partially active acetylcholine-receptor-drug complex from Xylocaine (or a derivative) and the active acetylcholine-receptor complex can account for the effects of Xylocaine and its derivatives at the neuromuscular junction. Transmembrane currents generated by an analogue computer programmed according to the scheme can exactly match end plate currents produced by nerve stimulation in the presence of the drugs. The scheme also accounts for the qualitatively different effects of the drugs on the end plate potential and on responses to iontophoretically applied acetylcholine. The analysis presented is consistent with very rapid reactions between acetylcholine and receptors, characterized by rate coefficients in the range 104 to 106 sec-'. It is based on the hypothesis that the activation of receptors by acetylcholine changes the structure of the receptors and thus their affinity for Xylocaine. The analysis does not require pharmacological separability of sodium and potassium conductances during the end plate current.Procaine, Xylocaine, and derivatives of Xylocaine depress and modify the response of the postsynaptic receptors of the neuromuscular junction to acetylcholine (ACh) (22,25). The most striking aspect of the effects of these drugs is the production of a prolonged component of the end plate potential (e.p.p.) that cannot be ascribed to an anticholinesterase action. In this respect, and in many other details, the actions of the drugs differ greatly from that of dtubocurarine (d-TC) and other chemicals that also depress the response of receptors. However, the site of action of Xylocaine and procaine, like that of d-TC, appears to be at the postsynaptic receptors (22,25). This suggests that these drugs modify the kinetics of the receptor response, although they do not produce a response themselves. Thus, an analysis of the effects of Xylocaine and procaine at the neuromuscular junction should offer the opportunity to find out more about the receptors themselves.